Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):463–468. doi: 10.1016/j.ijrobp.2013.02.009

Fig. 2.

Fig. 2

Efficacy of Genexol-PM as a radiosensitizer in non-small cell lung cancer cell lines in vitro. Radiation survival curves for (A) H460 and (B) A549 non-small cell lung cancer cells treated with saline, Taxol, or Genexol-PM. Cells were irradiated with 2 fractions of indicated doses 12 hours apart. Significant differences between Taxol and Genexol-PM at a given dose are indicated (P<.01, †P<.05). Error bars correspond to standard error of the mean (3 samples per time point). XRT = radiation therapy.